Indivior

Indivior is a global specialty pharmaceutical company dedicated to transforming patient lives through pioneering life-transforming therapies for addiction and other serious mental illnesses. Indivior develops and markets buprenorphine-based medications for the treatment of moderate to severe opioid use disorder in more than 40 countries worldwide. Indivior also sells a long-acting injectable treatment for adults with schizophrenia in the United States and recently announced a licensing agreement to bring this therapy to patients with schizophrenia in Canada.